Publications by authors named "L H Buehler"

Article Synopsis
  • The study aimed to assess how diabetes medications like metformin, DPP-4 inhibitors, and insulin affect COVID-19 hospitalization outcomes in type 2 diabetes patients, focusing on ICU admissions, ventilation needs, renal issues, and mortality.
  • Through a retrospective analysis of 529 hospitalized patients, it was found that neither metformin nor DPP-4 inhibitors impacted ICU admissions, ventilation requirements, or mortality rates, while insulin use was linked to more ICU admissions.
  • The results suggest that in this specific group, insulin may lead to higher ICU admission rates, but metformin and DPP-4 inhibitors did not show significant effects on critical health outcomes during COVID-19.
View Article and Find Full Text PDF

Background: This article summarizes a global study of the effect of the COVID-19 pandemic on junior health professions students' outlook on medicine. The pandemic has significantly affected health professions education. There is limited understanding of how students' pandemic experiences will affect them, and what impact these events may have on their career paths or the future of the professions.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the effects of early weight-based basal insulin alongside intravenous insulin infusion (IVII) on glycemic control in medical intensive care unit (MICU) patients.
  • Patients receiving the intervention showed significantly lower glucose levels 12 to 24 hours post-IVII compared to the control group, indicating improved glycemic management.
  • No significant increase in hypoglycemia rates was observed between both groups, suggesting the intervention is safe and effective.
View Article and Find Full Text PDF

Objective: The Alertgy noninvasive continuous glucose monitor (ANICGM) is a novel wristband device that reports glucose levels without entailing skin puncture. This study evaluated the performance of the ANICGM compared to a Food and Drug Administration-approved glucose meter in patients with type 2 diabetes.

Methods: The ANICGM device measures changes in the electromagnetic field generated by its sensor to produce a dielectric spectrum.

View Article and Find Full Text PDF